Wayne A.I. Frederick - 17 Jun 2021 Form 4 Insider Report for Forma Therapeutics Holdings, Inc. (FMTX)

Role
Director
Signature
/s/ Jeannette Potts, as Attorney-in-Fact
Issuer symbol
FMTX
Transactions as of
17 Jun 2021
Transactions value $
$0
Form type
4
Filing time
21 Jun 2021, 19:06:14 UTC
Previous filing
28 May 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FMTX Common Stock Award $0 +2.75K $0.00 2.75K 17 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FMTX Stock Option (Right to Buy) Award $0 +8.38K $0.00 8.38K 17 Jun 2021 Common Stock 8.38K $25.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
F2 This option shall vest and become exercisable in full upon the earlier to occur of (i) June 17, 2022 and (ii) the next annual meeting of the Issuer's stockholders.